Bioconjugation
Abzena and Telix sign strategic manufacturing and bioconjugation agreement
Abzena
PR-M07-18-NI-016Jul 06, 2018
Immuno-Oncology
European Commission Approves Bristol-Myers Squibb’s Yervoy (ipilimumab) for Treatment of Pediatric Patients 12 Years and Older with Unresectable or Metastatic Melanoma
Bristol-Myers Squibb
PR-M01-18-NI-082Jan 25, 2018
CRDMO
Creating a Global C‘R’DMO for the Future of (Bio)pharma: Effective Strategies and Tactics
Steven R. Hagen, Ph.D.; Dawn Von Rohr
Curia (formerly AMRI)
PAP-Q03-16-CL-001Aug 01, 2016
QbD
Quality by Design: Transforming 21st Century Pharmaceutical Manufacturing
John Moscariello, Ph.D.
PAP-Q03-16-CL-003Aug 01, 2016